Advertisement
ADP vs JNJ
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADP is a Hold and JNJ is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
JNJ’s FA Score shows that 4 FA rating(s) are green while.
- JNJ’s FA Score: 4 green, 1 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ADP’s TA Score shows that 3 TA indicator(s) are bullish while JNJ’s TA Score has 7 bullish TA indicator(s).
- ADP’s TA Score: 3 bullish, 6 bearish.
- JNJ’s TA Score: 7 bullish, 4 bearish.
Price Growth
JNJ (@Pharmaceuticals: Major) experienced а +4.81% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.79%. For the same industry, the average monthly price growth was +4.32%, and the average quarterly price growth was +10.25%.
Reported Earning Dates
JNJ is expected to report earnings on Oct 21, 2025.
Industries' Descriptions
@Pharmaceuticals: Major (+1.79% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
| ADP | JNJ | ADP / JNJ | |
| Capitalization | 103B | 380B | 27% |
| EBITDA | 5.51B | 23.3B | 24% |
| Gain YTD | 3.855 | 15.541 | 25% |
| P/E Ratio | 29.07 | 30.34 | 96% |
| Revenue | 17.7B | 85.2B | 21% |
| Total Cash | 1.64B | 22.9B | 7% |
| Total Debt | 3.32B | 29.3B | 11% |
ADP | JNJ | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 72 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 8 | 29 | |
SMR RATING 1..100 | 15 | 33 | |
PRICE GROWTH RATING 1..100 | 54 | 31 | |
P/E GROWTH RATING 1..100 | 37 | 81 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ADP's Valuation (13) in the Data Processing Services industry is in the same range as JNJ (20) in the Pharmaceuticals Major industry. This means that ADP’s stock grew similarly to JNJ’s over the last 12 months.
ADP's Profit vs Risk Rating (8) in the Data Processing Services industry is in the same range as JNJ (29) in the Pharmaceuticals Major industry. This means that ADP’s stock grew similarly to JNJ’s over the last 12 months.
ADP's SMR Rating (15) in the Data Processing Services industry is in the same range as JNJ (33) in the Pharmaceuticals Major industry. This means that ADP’s stock grew similarly to JNJ’s over the last 12 months.
JNJ's Price Growth Rating (31) in the Pharmaceuticals Major industry is in the same range as ADP (54) in the Data Processing Services industry. This means that JNJ’s stock grew similarly to ADP’s over the last 12 months.
ADP's P/E Growth Rating (37) in the Data Processing Services industry is somewhat better than the same rating for JNJ (81) in the Pharmaceuticals Major industry. This means that ADP’s stock grew somewhat faster than JNJ’s over the last 12 months.
| ADP | JNJ | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 1 day ago 32% |
| Stochastic ODDS (%) | 1 day ago 53% | 1 day ago 47% |
| Momentum ODDS (%) | 1 day ago 33% | 1 day ago 42% |
| MACD ODDS (%) | 1 day ago 28% | 1 day ago 39% |
| TrendWeek ODDS (%) | 1 day ago 55% | 1 day ago 40% |
| TrendMonth ODDS (%) | 1 day ago 47% | 1 day ago 38% |
| Advances ODDS (%) | 6 days ago 57% | 1 day ago 40% |
| Declines ODDS (%) | 2 days ago 43% | 8 days ago 43% |
| BollingerBands ODDS (%) | N/A | 1 day ago 36% |
| Aroon ODDS (%) | 1 day ago 40% | 1 day ago 40% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IQDF | 27.51 | 0.24 | +0.88% |
| FlexShares Intl Qual Div ETF | |||
| XDQQ | 35.74 | 0.17 | +0.49% |
| Innovator Gr 100 Acltd ETF™ Quarterly | |||
| EMNT | 98.63 | 0.02 | +0.03% |
| PIMCO Enhanced Short Mtrty Actv ESG ETF | |||
| YBIT | 10.82 | -0.04 | -0.37% |
| YieldMax Bitcoin Option Income Strategy ETF | |||
| SCHA | 25.96 | -0.12 | -0.46% |
| Schwab US Small-Cap ETF™ | |||
ADP and
Correlation & Price change
A.I.dvisor indicates that over the last year, ADP has been closely correlated with PAYX. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if ADP jumps, then PAYX could also see price increases.
| Ticker / NAME | Correlation To ADP | 1D Price Change % | ||
|---|---|---|---|---|
| ADP | 100% | -0.29% | ||
| PAYX - ADP | 74% Closely correlated | +0.20% | ||
| NSP - ADP | 38% Loosely correlated | +1.09% | ||
| TNET - ADP | 34% Loosely correlated | -0.25% | ||
| UPWK - ADP | 28% Poorly correlated | +1.13% | ||
| MAN - ADP | 27% Poorly correlated | -2.61% | ||
More | ||||